These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 29633886)

  • 1. Comorbidities, risk factors and outcomes in patients with heart failure and an ejection fraction of more than or equal to 40% in primary care- and hospital care-based outpatient clinics.
    Eriksson B; Wändell P; Dahlström U; Näsman P; Lund LH; Edner M
    Scand J Prim Health Care; 2018 Jun; 36(2):207-215. PubMed ID: 29633886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited value of NT-proBNP as a prognostic marker of all-cause mortality in patients with heart failure with preserved and mid-range ejection fraction in primary care: A report from the swedish heart failure register.
    Eriksson B; Wändell P; Dahlström U; Näsman P; Lund LH; Edner M
    Scand J Prim Health Care; 2019 Dec; 37(4):434-443. PubMed ID: 31724475
    [No Abstract]   [Full Text] [Related]  

  • 3. Etiology of Heart Failure and Outcomes in Patients Hospitalized for Acute Decompensated Heart Failure With Preserved or Reduced Ejection Fraction.
    Kajimoto K; Minami Y; Sato N; Kasanuki H;
    Am J Cardiol; 2016 Dec; 118(12):1881-1887. PubMed ID: 27720439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-Based Differences in Heart Failure Across the Ejection Fraction Spectrum: Phenotyping, and Prognostic and Therapeutic Implications.
    Stolfo D; Uijl A; Vedin O; Strömberg A; Faxén UL; Rosano GMC; Sinagra G; Dahlström U; Savarese G
    JACC Heart Fail; 2019 Jun; 7(6):505-515. PubMed ID: 31146874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of left ventricular ejection fraction and clinical features or co-morbidities to outcomes among patients hospitalized for acute heart failure syndromes.
    Kajimoto K; Sato N; Takano T;
    Am J Cardiol; 2015 Feb; 115(3):334-40. PubMed ID: 25476557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction.
    Lund LH; Benson L; Dahlström U; Edner M
    JAMA; 2012 Nov; 308(20):2108-17. PubMed ID: 23188027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis, Clinical Course, and 1-Year Outcome in Patients Hospitalized for Heart Failure With Preserved Ejection Fraction (from the Polish Cohort of the European Society of Cardiology Heart Failure Long-Term Registry).
    Kapłon-Cieślicka A; Tymińska A; Peller M; Balsam P; Ozierański K; Galas M; Marchel M; Crespo-Leiro MG; Maggioni AP; Drożdż J; Filipiak KJ; Opolski G
    Am J Cardiol; 2016 Aug; 118(4):535-42. PubMed ID: 27374606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
    Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
    Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between cardiovascular vs. non-cardiovascular co-morbidities and outcomes in heart failure with preserved ejection fraction.
    Lund LH; Donal E; Oger E; Hage C; Persson H; Haugen-Löfman I; Ennezat PV; Sportouch-Dukhan C; Drouet E; Daubert JC; Linde C;
    Eur J Heart Fail; 2014 Sep; 16(9):992-1001. PubMed ID: 25046483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic obstructive airway disease among patients hospitalized with acute heart failure; clinical characteristics, precipitating factors, management and outcome: Observational report from the Middle East.
    Khafaji HA; Sulaiman K; Singh R; Alhabib KF; Asaad N; Alsheikh-Ali A; Al-Jarallah M; Bulbanat B; Almahmeed W; Ridha M; Bazargani N; Amin H; Al-Motarreb A; Faleh HA; Elasfar A; Panduranga P; Suwaidi JA
    Acute Card Care; 2015 Dec; 17(4):55-66. PubMed ID: 27712142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fraction.
    Lund LH; Benson L; Dahlström U; Edner M; Friberg L
    JAMA; 2014 Nov; 312(19):2008-18. PubMed ID: 25399276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term and clinical profile of heart failure with recovered ejection fraction in a non-tertiary hospital.
    Martínez-Mateo V; Fernández-Anguita M; Cejudo L; Martín-Barrios E; Paule AJ
    Med Clin (Barc); 2019 Jan; 152(2):50-54. PubMed ID: 29884453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of atrial fibrillation on the mortality of patients with heart failure with preserved ejection fraction.
    Franco J; Formiga F; Cepeda J; Llacer P; Arévalo-Lorido J; Cerqueiro J; González-Franco A; Epelde F; Manzano L; Montero Pérez-Barquero M;
    Med Clin (Barc); 2018 May; 150(10):376-382. PubMed ID: 28870424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex differences in in-hospital mortality in acute decompensated heart failure with reduced and preserved ejection fraction.
    Hsich EM; Grau-Sepulveda MV; Hernandez AF; Peterson ED; Schwamm LH; Bhatt DL; Fonarow GC
    Am Heart J; 2012 Mar; 163(3):430-7, 437.e1-3. PubMed ID: 22424014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics, precipitating factors, management and outcome of patients with prior stroke hospitalised with heart failure: an observational report from the Middle East.
    Khafaji HA; Sulaiman K; Singh R; AlHabib KF; Asaad N; Alsheikh-Ali A; Al-Jarallah M; Bulbanat B; AlMahmeed W; Ridha M; Bazargani N; Amin H; Al-Motarreb A; AlFaleh H; Elasfar A; Panduranga P; Al Suwaidi J
    BMJ Open; 2015 Apr; 5(4):e007148. PubMed ID: 25908674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between relevant co-morbidities and prevalent as well as incident heart failure in patients with atrial fibrillation.
    Wändell P; Carlsson AC; Holzmann MJ; Ärnlöv J; Sundquist J; Sundquist K
    J Cardiol; 2018 Jul; 72(1):26-32. PubMed ID: 29358024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry.
    Canepa M; Straburzynska-Migaj E; Drozdz J; Fernandez-Vivancos C; Pinilla JMG; Nyolczas N; Temporelli PL; Mebazaa A; Lainscak M; Laroche C; Maggioni AP; Piepoli MF; Coats AJS; Ferrari R; Tavazzi L;
    Eur J Heart Fail; 2018 Jan; 20(1):100-110. PubMed ID: 28949063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical characteristics and outcomes of heart failure patient with chronic obstructive pulmonary disease from the Japanese community-based registry.
    Takabayashi K; Terasaki Y; Okuda M; Nakajima O; Koito H; Kitamura T; Kitaguchi S; Nohara R
    Heart Vessels; 2021 Feb; 36(2):223-234. PubMed ID: 32770265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
    Kontogeorgos S; Thunström E; Johansson MC; Fu M
    Int J Cardiol; 2017 Apr; 232():86-92. PubMed ID: 28100428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of Ischemic Heart Disease in Patients With Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction: A Nationwide Cohort Study.
    Vedin O; Lam CSP; Koh AS; Benson L; Teng THK; Tay WT; Braun OÖ; Savarese G; Dahlström U; Lund LH
    Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28615366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.